| Literature DB >> 34849678 |
Eivind Sørensen1,2, Marius Myrstad3,4, Magnar Gangås Solberg2,3,4, Erik Øie1, Arnljot Tveit3,4, Marit Aarønæs1.
Abstract
AIMS: To assess left atrial (LA) function in sinus rhythm in veteran athletes with a history of paroxysmal atrial fibrillation (AF) exposed to prolonged endurance exercise compared with veteran athletes without AF and controls with and without paroxysmal AF from a non-athletic population. METHODS ANDEntities:
Keywords: athlete; atrial fibrillation; atrium; diastolic function; exercise; strain
Mesh:
Year: 2021 PMID: 34849678 PMCID: PMC8685599 DOI: 10.1093/ehjci/jeab248
Source DB: PubMed Journal: Eur Heart J Cardiovasc Imaging ISSN: 2047-2404 Impact factor: 6.875
Baseline characteristics
| Athletes | Non-athletes | |||
|---|---|---|---|---|
| AF | No AF | AF | No AF | |
| Age (years) |
|
|
|
|
| Weight (kg) |
|
|
|
|
| Height (m) |
|
|
|
|
| Body mass index (kg/m2) |
|
|
|
|
| DBP (mmHg) |
|
|
|
|
| SBP (mmHg) |
|
|
|
|
| Heart rate (beats/min) |
|
|
|
|
| CHA2DS2-VASc score |
|
|
|
|
| Higher education, |
|
|
|
|
| Anti-hypertensive treatment, |
|
|
|
|
| Diabetes, |
|
|
|
|
| Current smoking, |
|
|
|
|
| Previous ablation, | 22 (35.5) | 14 (22.6) | ||
| Beta-blocker, | 12 19.4) | 24 (38.7) | ||
| Calsium-channel blocker, | 1 (1.6) | 4 (6.5) | ||
| Amiodarone, | 2 (3.2) | 3 (4.8) | ||
| Flecainid, | 3 (4.8) | 7 (11.3) | ||
| Digoxin, | 0 (0.0) | 0 (0.0) | ||
| Use of oral anticoagulants CHA2DS2-VASc score |
| 29/37 (84%) | ||
| Use of oral anticoagulants CHA2DS2-VASc-score |
| 13/25 (52%) | ||
| Number of completed Birkebeiner ski races |
|
| ||
| Still participating in regular endurance exercise (%) | 46 (75.8%) | 68 (75.8%) | 11 (17.7%) | 8 (9.3%) |
Values are expressed as meanSD, n (%), or median (interquartile range).
DBP, diastolic blood pressure; SBP, systolic blood pressure.
CHA2DS2-VASc score estimated based on age, sex, CHF history, hypertension, stroke, coronary heart disease and diabetes mellitus.
Left atrium echocardiographic values
P-value interaction athletic status and AF status
| Athletes | Non-athletes | ||||||
|---|---|---|---|---|---|---|---|
| AF | No AF | AF | No AF |
|
| P-value interaction athletic status and AF status | |
| LASr (%) |
|
|
|
| 0.410 | <0.001 | 0.673 |
| LAScd (%) |
|
|
|
| 0.788 | <0.001 | 0.955 |
| LASct (%) |
|
|
|
| 0.215 | <0.001 | 0.591 |
| LAEF (%) |
|
|
|
| 0.204 | <0.001 | 0.546 |
| LAVImax (mL/m2) |
|
|
|
| <0.001 | <0.001 | 0.867 |
| LAVImin (mL/m2) |
|
|
|
| <0.001 | <0.001 | 0.997 |
| LA passive emptying fraction (%) |
|
|
|
| 0.247 | 0.020 | 0.090 |
| LA active emptying fraction (%) |
|
|
|
| 0.013 | <0.001 | 0.970 |
| LA stiffness |
|
|
|
| 0.052 | <0.001 | 0.948 |
Values are expressed as meanSD. Two-way between groups analysis of variance was conducted. P-values for the main effects of athletic status and AF status as well as the interaction are presented in the table.
LA, left atrial; LAEF, left atrial ejection fraction; LAScd, Left atrial conduit strain; LASct, Left atrial contractile strain; LASr, Left atrial reservoir strain; LAVImax, maximum left atrial volume index; LAVImin, minimum left atrial volume index.
Performance of atrial volumes and functional parameters at identifying athletes with AF
| Variable | AUC |
|
|---|---|---|
| LASr |
| 0.000 |
| LAScd |
| 0.012 |
| LASct |
| 0.000 |
| LAEF |
| 0.000 |
| LA conduit fraction |
| 0.928 |
| LA pump fraction |
| 0.000 |
| LAVImax |
| 0.008 |
| LAVIPa |
| 0.034 |
| LAVImin |
| 0.000 |
AUC, area under the curve; LAEF, left atrial ejection fraction; LAScd, left atrial conduit strain; LASct, left atrial contractile strain; LASr, left atrial reservoir strain; LAVImax, maximum left atrial volume indexed; LAVImin, minimum left atrial volume indexed; LAVIPa, left atrial preatrial contraction volume indexed.
Left ventricular echocardiographic parameters
| Athletes | Non-athletes | ||||||
|---|---|---|---|---|---|---|---|
| AF | No AF | AF | No AF |
|
|
| |
| GLS (%) |
|
|
|
| 0.009 | 0.606 | 0.169 |
| Ejection fraction (%) |
|
|
|
| <0.001 | 0.016 | 0.070 |
| Peak mitral |
|
|
|
| <0.001 | 0.842 | 0.750 |
| Peak mitral |
|
|
|
| <0.001 | <0.001 | 0.525 |
|
|
|
|
|
| 0.427 | <0.001 | 0.600 |
|
|
|
|
|
| 0.003 | 0.417 | 0.156 |
| Average |
|
|
|
| 0.789 | 0.509 | 0.177 |
| EDecT (ms) |
|
|
|
| 0.006 | 0.410 | 0.670 |
| LVEDV indexed (mL/m2) |
|
|
|
| <0.001 | 0.028 | 0.157 |
| LVESV indexed (mL/m2) |
|
|
|
| <0.001 | 0.008 | 0.068 |
| LV mass index (g/m2) |
|
|
|
| <0.001 | 0.075 | 0.004 |
| Indexed LA/LV ratio |
|
|
|
| 0.368 | 0.079 | 0.271 |
| Stroke volume indexed (mL/beat/m2) |
|
|
|
| 0.005 | 0.967 | 0.189 |
Values are expressed as meanSD. Two-way between groups analysis of variance was conducted. P-values for the main effects of athletic status and AF status as well as interaction are presented in the table.
AF, atrial fibrillation; EDecT, E deceleration time; EDV, end-diastolic volume; ESV, end-systolic volume; GLS, Global longitudinal strain; LA, Left atrium; LV, left ventricle.